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PATIENTS AND METHODS
Between January 1983 and December 1999, 33 patients
who had RCC associated with IVC tumor thrombus under-
went 34 surgical procedures. The 27 men and six women
had an average age of 60.1 years, ranging from 34 to 79
years. RCC involved the right and left kidneys in 30 and
three patients, respectively. One patient had redo operation
for recurrent IVC tumor thrombus 2 years after his radical
nephrectomy and complete vena caval thrombectomy.
All of the 33 patients presented with symptoms for
RCC; 28 had hematuria and 23 had abdominal or flank
pain. Bilateral leg edema due to IVC obstruction was
found in eight patients (24.2%). No patients presented
with evidence of hepatic vein obstruction, such as ascites
or hematemesis from esophageal varices.
All patients preoperatively underwent routine blood
tests, chest radiography, and renal arteriography to 
evaluate the tumor vascularity. Computed tomography
(CT) and magnetic resonance imaging (MRI) of the
abdomen were also performed to assess the existence of
tumor thrombus, gross lymph node involvement, and
metastatic disease. The level of tumor extension into the
IVC could be exactly estimated by contrast enhanced
CT and sagittal view of MRI. A bone scan, venacavog-
raphy, chest CT, and/or brain CT were also obtained in
some patients.
Tumor thrombus extended into the inferior vena cava
(IVC) is occasionally found in the advanced stage of
malignant neoplasms, such as retroperitoneal tumors,
gynecologic tumors, hepatocellular carcinoma, and renal
cell carcinoma (RCC).1-4
RCC, which has a tendency for vascular invasion,
extends into the IVC in 4% to 25% of all patients.5-8 In
patients with nonmetastatic RCC who underwent radical
nephrectomy and complete thrombectomy, 5-year survival
rates of 30% to 72% have been reported.9-11 However, sur-
gical indication for patients with metastatic RCC and the
use of cardiopulmonary bypass (CPB) during vena caval
thrombectomy are still controversial. Prognosis-limiting
factors of patients who underwent radical nephrectomy
and complete thrombectomy are also uncertain. In this
study we retrospectively analyzed the surgical outcome of
patients who had RCC with IVC tumor thrombi.
789
From the Departments of Surgery, Division II,a and Urology,b Kobe
University School of Medicine.
Competition of interest: nil.
Reprint requests: Y. Tsuji, MD, Department of Surgery, Division II, Kobe
University School of Medicine, 7-5-2, Kusunoki-Cho, Chuo-Ku, Kobe
650-0017, Japan.
Copyright © 2001 by The Society for Vascular Surgery and The American
Association for Vascular Surgery.
0741-5214/2001/$35.00 + 0 24/1/111996
doi:10.1067/mva.2001.111996
Renal cell carcinoma with extension of tumor
thrombus into the vena cava: Surgical strategy
and prognosis
Yoshihiko Tsuji, MD,a Akinobu Goto, MD,b Isao Hara, MD,b Keiji Ataka, MD,a Chojiro Yamashita,
MD,a Yutaka Okita, MD,a and Sadao Kamidono, MD,b Kobe, Japan
Purpose: The outcome of patients who underwent radical resection of renal cell carcinoma extending into the vena cava
was retrospectively analyzed, and risk factors for long-term survival were investigated.
Methods: From 1983 to 1999, 33 patients who had renal cell carcinoma with inferior vena caval tumor extension under-
went 34 surgical procedures. There were 27 men and six women with an average age of 60.1 years. Twenty-two cases
(64.7%) were classified as stage III (T1-2 N1 M0 or T3 N0-1 M0), and 12 cases (35.3%) as stage IV (T4 or N2-3 or
M1). Coexistent lung metastasis was found in seven cases (20.6%). The tumor thrombi invaded into the inferior vena
cava below the hepatic hilum in 19 cases, below the orifice of hepatic veins in 12, and above the diaphragm in 3.
Cardiopulmonary bypass graft was applied in 13 cases (38.2%). Inferior vena cava was reconstructed by direct suture
(n = 19), polytetrafluoroethylene patch angioplasty (n = 13), or graft replacement (n = 2).
Results: Two patients died during the early postoperative period because of retrohepatic caval injury and intraoperative
pulmonary embolism. Late death occurred in 16 patients; the causes of death were tumor recurrence in 15 and acute
pulmonary embolism as a result of graft thrombosis in 1. Overall 1-, 5-, and 10-year survival rates were 70%, 44%, and
26.4%, respectively. One- and 5-year survival rates were 81.3% and 52.9% for stage III and 50% and 31.2% for stage
IV; a statistically significant correlation was found between surgical staging and survival (P = .049). Patients without
lymph node metastasis had a significant survival advantage over those with lymph node metastasis (P = .022). There
was no significant difference in survival on the basis of the presence or absence of synchronous lung metastasis (P =
.291). The degree of local extension of the tumor or the level of tumor thrombus did not tend to influence survival.
Conclusions: Surgical prognosis in patients with renal cell carcinoma extending into the vena cava was determined by
the staging of the tumor, especially lymph node status, and not by the level of tumor thrombus or the presence of con-
current lung metastasis. The use of cardiopulmonary bypass graft is recommended for the resection of tumor throm-
bus extending over the diaphragm. (J Vasc Surg 2001;33:789-96.)
Staging system. Surgical staging was done according
to TNM classification (TNM Atlas, third edition, 2nd
revision, 1992) of UICC (Union Internationale Contre le
Cancer). Twenty-two cases (64.7%) were classified as stage
III (T1-2 N1 M0 or T3 N0-1 M0) and 12 cases (35.3%)
as stage IV (T4, N2-3, or M1) (Table I). Concurrent dis-
tant metastasis was recognized in seven cases (20.6%), and
all of them were lung metastasis. The extension levels of
tumor thrombi were defined by three categories: Va,
below the hepatic hilum (n = 19); Vb, below the junction
of hepatic veins (n = 12); and Vc, above the diaphragm 
(n = 3) (Fig 1). Patients with tumor thrombus localized
within the renal vein were excluded from this study.
Surgical procedures. The operative techniques
changed during this time period. In the first several cases,
CPB was used in all cases. Surgical experience clarified that
the total clamp of IVC below the orifice of hepatic veins
without CPB did not induce hypotension or intestinal con-
gestion; thus recently CPB has been applied only in cases of
level Vc tumor. Present surgical details are as follows. In
supine position, transesophageal echocardiography (TEE)
probe was inserted after endotracheal intubation. With the
use of intraoperative TEE, vascular clamp could be made
exactly above the head of tumor thrombus, intraoperative
pulmonary embolism could be diagnosed immediately, and
the residual tumor thrombus into the IVC could be
observed. Median laparotomy was used, and the IVC and
the renal veins were exposed. In the case of level Va tumor,
the vascular isolations were made on the IVC below the
hepatic hilum, the infrarenal IVC, and the contralateral
renal vein. The tumor thrombus was then removed through
the longitudinal cavotomy incised from the level of the head
of tumor thrombus to the orifice of renal vein. For level Vb
tumor, an additional right subcostal incision was occasion-
ally required to expose the retrohepatic IVC with mobiliza-
tion of the right hepatic lobe. The vascular isolations of the
IVC below the orifice of hepatic veins, the infrarenal IVC,
and the contralateral renal vein were made without CPB,
and the tumor thrombus was removed through the longi-
tudinal cavotomy incised from the level of the head of
tumor thrombus to the orifice of renal vein. In the case of
level Vc tumor, an additional median sternotomy was per-
formed, and the IVC below the cavoatrial junction was iso-
lated. After heparinization, the femoral artery and vein were
cannulated and normothermic partial CPB was started. The
vascular isolations of the IVC below the cavoatrial junction,
the infrarenal IVC, and the contralateral renal vein were
made. The tumor thrombus was removed through the lon-
gitudinal cavotomy, while bleeding from the hepatic veins
was sucked and returned in the CPB circulation. A Pringle
maneuver was occasionally used to reduce the bleeding
from hepatic veins. Suture closure or patch angioplasty was
started from the proximal end, and CPB was weaned after
closure of hepatic portion of the IVC. When the tumor
thrombus extended into the right atrium, secondary venous
cannula was placed in the superior vena cava. Then the
tumor was removed through a right atriotomy under total
CPB and electrically induced ventricular fibrillation. No sys-
temic cooling or cardiac arrest was necessary.
When the wall of the IVC was invaded by the tumor,
the infiltrated portion was resected with an appropriate sur-
gical margin. Depending on the defect size, the IVC was
closed directly or reconstructed by polytetrafluoroethylene
(PTFE) patch angioplasty or PTFE graft replacement.
Follow-up and statistical methods. Patients, if their
physiologic conditions permitted, received postoperative
immunotherapy with interferon. All surviving patients were
contacted at the time of data collection to determine disease
status. Mean follow-up period was 31 months, ranging from
1 to 136 months. Survival time was calculated from the date
of operation to date of death or last contact. Survival curves
were calculated with the Kaplan-Meier method. Statistical
difference between survival of subgroups was tested with the
log-rank test, in case propriety of rank test was verified by the
comparison of each cumulative hazard curve.
RESULTS
Intraoperative findings. Radical nephrectomy with
tumor thrombectomy was performed in all patients. The
IVC occluded by the tumor thrombus was generally
enlarged, and the average diameter was 40.1 mm (range,
30-50 mm). Surgical approaches used were median laparo-
tomy in 20 cases, median laparotomy with right subcostal
incision in 5, and with sternotomy in 9 (Table II). CPB was
used in 13 cases (38.2%), and mean CPB time was 50.7
minutes (range, 35-75 minutes). The IVC reconstructions
were performed with direct closure in 19 cases, PTFE
patch angioplasty in 13, and PTFE graft replacement in 2.
Mean operative time was 405 minutes (range, 185-655
minutes), and the average blood loss was 2.5 L (range, 0.3-
12 L). When categorized by surgical stage, 21 patients had
stage III disease, and 12 had stage IV.
Operative results. Two operation-related deaths were
encountered. A male patient with a level Vb tumor throm-
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Table I. TNM staging of renal cell carcinoma with IVC
tumor thrombus
Stage T N M No. of cases
III 3b 0 0 19
3b 1 0 2
3c 0 0 1
Total 22
IV 3b 0 1 5
3b 1 1 1
3b 2 0 1
3b 2 1 1
3c 2 0 2
4 0 0 2
Total 12
T3, tumor with perinephric invasion within Gerota’s fascia; T3b, tumor
with venous invasion extended to the infradiaphragmatic IVC; T3c, tumor
with venous invasion extended to the supradiaphragmatic IVC; T4, tumor
with perinephric invasion extended over Gerota’s fascia. N0, no lymph
node metastasis; N1, one metastatic lymph node of 2 cm or less; N2, some
metastatic lymph nodes of 5 cm or less; N3, some metastatic lymph nodes
greater than 5 cm. M0, no distant metastasis; M1, with distant metastasis.
bus underwent thrombectomy through the incision made
on infrahepatic IVC. The retrohepatic IVC was accidentally
torn during the procedure because the tumor thrombus was
firmly invaded to the IVC wall. He died 15 days after oper-
ation of multiple organ failure induced by massive bleeding.
The other patient was a man with a level Vb tumor throm-
bus. Sudden hypotension because of acute pulmonary
embolism occurred during dissection around the right kid-
ney. Emergency pulmonary thrombectomy was attempted
under CPB; however, he died 1 day later of acute heart fail-
ure. The other 31 patients had no fatal complications, such
as hepatic or renal failure, during their hospital stay.
Prognosis and long-term survival. Sixteen (51.6%)
of 31 early survivors died during follow-up. A woman who
underwent IVC reconstruction with PTFE tubular graft
died suddenly 1 month after surgery, and the cause of
death was suspected to be acute pulmonary embolism as a
result of graft thrombosis. The remaining 15 patients died
of local recurrence or distant metastasis of RCC. Fifteen
patients survive after surgery, with metastatic disease in
five and without in 10. Overall 1-, 5-, and 10-year survival
rates, including two cases of operation-related death, were
70%, 44%, and 26.4%, respectively (Fig 2).
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One- and 5-year survival rates were 81.3% and 52.9%
for stage III and 50% and 31.2% for stage IV (Fig 3). A
statistically significant correlation was found between sur-
gical staging and survival (P = .049). Patients without
lymph node metastasis had a significant survival advantage
over those with lymph node metastasis (Fig 4, P = .022).
There was no significant difference in survival based on
the presence or absence of synchronous lung metastasis
(Fig 5, P = .291). The degree of local extension of the
tumor (T factor) or the level of tumor thrombus (V fac-
tor) did not tend to influence survival (Figs 6 and 7); how-
ever, statistical rank test could not be performed.
DISCUSSION
In 1913 Berg12 first reported nephrectomy and
venacavotomy for RCC extended into the IVC. Since this
report, radical nephrectomy with vena caval thrombectomy
has become a standard treatment for this entity. The opera-
tive mortality rates previously reported ranged from 2.7% to
13%9,10,13-15; those were very compatible with our results.
In this series we encountered two cases (5.9%) of operation-
related death; one of them was caused by massive bleeding,
and the other one was suspected to be caused by intraoper-
Fig 1. Classification of extension level of tumor thrombus into IVC: Va, tumor thrombus below hepatic hilum; Vb, tumor thrombus
below orifice of hepatic veins; Vc, tumor thrombus above diaphragm. RK, Right kidney; LK, left kidney; RHV, right hepatic vein; MHV,
middle hepatic vein; LHV, left hepatic vein; IVC, inferior vena cava.
Table II. Surgical approach and the use of CPB
Level of tumor thrombus Surgical approach n With CPB
Va (n = 19) Median laparotomy 17 0
Median laparotomy with sternotomy 2 2
Vb (n = 12) Median laparotomy 3 1
Median laparotomy with right subcostal incision 5 3
Median laparotomy with sternotomy 4 4
Vc (n = 3) Median laparotomy with sternotomy 3 3
Total 34 13
ative pulmonary tumor embolism. The former one was the
initial case of this series, and blunt thrombectomy with bal-
loon catheter was performed without complete exposure of
the retrohepatic IVC. We now consider that tumor throm-
bus must be resected under complete exposure and isola-
tion of the IVC under liberal use of CPB. Blunt
thrombectomy with balloon catheter is now never per-
formed because of IVC injury, pulmonary embolism, and
tumor residual on the IVC wall. The latter patient died of
pulmonary tumor embolism, which is also one of the fatal
complications of this surgery.16,17 TEE is valuable for intra-
operative monitoring of IVC tumor thrombus and can
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Fig 3. Cumulative survival based on surgical stage with Kaplan-Meier method (log-rank test = .049). Dashed lines indicate SE > 10%.
Fig 2. Overall survival rate with Kaplan-Meier method.
diagnose pulmonary embolism with disappearance of the
tumor head, dislodging of the tumor into pulmonary arter-
ies, or any sign of right heart dysfunction.18 For the pre-
vention of pulmonary tumor embolism, gentle surgical
maneuver and intraoperative hemodynamic stability may be
necessary.
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When the tumor thrombus invades the IVC wall, partial
or total circumferential resection of the IVC with adequate
surgical margin is necessary. However, the indication and
method of venous reconstruction after resection of
suprarenal IVC are not yet established. Duckett et al19 indi-
cated that suprarenal IVC resection without venous replace-
Fig 4. Comparison of survival based on lymph node status with Kaplan-Meier method (log-rank test = .022). Dashed lines indicate SE > 10%.
Fig 5. Comparison of survival based on distant metastasis with Kaplan-Meier method (log-rank test = .291). Dashed lines indicate SE > 10%.
ment can be well tolerated because collateral pathways such
as the lumbar and epigastric pathways, renal veins, and ver-
tebral system are well developed by chronic occlusion of the
IVC. On the other hand, some authors suggested that
venous reconstruction after suprarenal IVC resection is
advisable because large dissection of a retroperitoneal tumor
and a thoracoabdominal incision can both interrupt ascend-
ing venous pathways and carry the risk of major venous
insufficiency.2,20 In this series, venous reconstruction was
performed in all cases to prevent unexpected venous insuffi-
ciency. When the wall defect was less than one third of the
circumference of the IVC, cavotomy was closed directly.
When the wall defect was more than one third of the cir-
cumference of the IVC, venous reconstruction was per-
formed with PTFE patch or tubular graft. Total replacement
of the IVC with PTFE graft was first reported by Sarti21 in
1970. Since this report, the IVC reconstruction with PTFE
tubular graft for malignant tumors was reported with excel-
lent long-term patency.2-4,20,22 However, we are prudent to
perform total circumferential replacement of the IVC with
prosthetic graft, because one of our patients died of pul-
monary embolism after graft thrombosis during the follow-
up period. Patch angioplasty with PTFE or autogenous
pericardium is now our first choice for the IVC repair if the
venous wall is not entirely invaded.
Techniques of caval control during thrombectomy will
vary depending on the location of tumor thrombus. If the
tumor thrombus is still limited below the level of hepatic
veins (Va and Vb), vascular isolation can be obtained by
clamps of the IVC and the contralateral renal vein without
any circulatory support. If the tumor thrombus is present
above the level of hepatic veins (Vc), some circulatory sup-
ports or hepatic vascular exclusion (HVE) is necessary dur-
ing cross-clamping of the IVC. HVE is a well-established
technique for vascular isolation during liver resection. With
this technique, bleeding through hepatic veins during cavo-
tomy is remarkably reduced and IVC tumor can be resected
with excellent exposure. If hypotension induced by venous
return decreases as a result of HVE, venovenous bypass is
available to stabilize hemodynamic conditions.22,23 Some
investigators recommend the use of HVE during resection
of IVC tumor, because it makes the control of the most
inaccessible portion of IVC easier and safer.2,15,24,25 For
example, Nesbitt et al15 indicated that even some of intra-
atrial tumor thrombus could be resected without CPB.
Their maneuver was to gently palpate the tumor at the
cavoatrial junction and manipulate the tumor into the
suprahepatic IVC; a vascular cross-clamp was then applied
across the IVC below the cavoatrial junction; cavotomy was
made and tumor thrombus was removed under HVE.
However, small veins that drain directly into retrohepatic
IVC, such as short hepatic veins, inferior phrenic veins, ver-
tebral veins, or right adrenal veins, sometimes become a
major collateral system as a result of chronic IVC occlusion.
Backflow from these veins brings unexpected bleeding from
cavotomy even in the presence of HVE. To preserve the
blood from lumbar and hepatic veins, some investigators
recommend the use of a cell-saving device associated with
HVE procedure.13,15 The use of a cell-saving device may
reduce total amount of blood transfusion; however, it is
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Fig 6. Comparison of survival based on degree of tumor extension with Kaplan-Meier method. Dashed lines indicate SE > 10%.
helpless against intraoperative massive bleeding with
hypotension. Thus, we routinely use normothermal CPB
without cardiac arrest during the resection of IVC tumor
extending above the level of hepatic veins. With the use of
CPB, the bleeding can be sucked and immediately returned
in the CPB circuit. The use of CPB stabilizes hemodynamic
conditions during IVC isolation and brings complete tumor
resection and venous reconstruction. The risk of CPB use
may be a possibility of tumor dissemination; however, some
reports indicated that the use of extracorporeal circulation
during the resection of tumor thrombus in the IVC did not
affect long-term survival.9,15
Some previous studies have indicated that there was
worse survival in the group of patients with a more proxi-
mal extension of tumor thrombus of RCC.9,14,26,27 Sosa
et al27 reported a 2-year survival rate of 80% in patients
with retrohepatic IVC thrombus compared with only 21%
in those with suprahepatic thrombus. Skinner et al14 indi-
cated a 5-year survival rate of 35% in patients with infra-
hepatic IVC thrombus compared with 18% and 0% in
those with retrohepatic IVC or intra-atrial thrombi,
respectively. On the other hand, some reports indicated
that the level of the thrombus had no statistically signifi-
cant impact on survival.15,28-30 Glazer and Novick31
reviewed 18 patients with RCC with IVC thrombus
extending into the right atrium and concluded that their
long-term survival was not significantly different from that
reported for patients with RCC and infrahepatic or retro-
hepatic IVC thrombi. Hatcher et al13 indicated that prog-
nosis in such cases was determined by the pathologic stage
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of the RCC and by the presence or absence of vena caval
wall invasion but not by the level of tumor thrombus
extension. In our patients the level of tumor thrombus (V
factor) did not tend to influence survival. A statistically
significant correlation was found between surgical staging
and survival; the presence of lymph node metastasis was an
especially potent risk factor for late death.
Surgical indication for RCC with distant metastasis is
controversial. Montie et al9 found that a patient with
metastatic disease was 2.76 times more likely to die than a
patient without metastasis. Suggs et al32 reviewed 26
patients who underwent radical nephrectomy and vena
caval thrombectomy, and all five patients who had distant
metastatic disease did not survive beyond 12 months.
Swierzewski et al30 reported surgical prognosis in 100 cases
of RCC extending into the IVC and concluded that the
presence of metastatic disease or nodal involvement pre-
cludes consideration of vena caval surgery because its sur-
vival rate was significantly poor. On the other hand, Nesbitt
et al15 indicated that distant metastases did not significantly
alter the prognosis although lymph node metastases had an
associated poor survival rate. Naitoh et al33 reviewed 31
patients with RCC with tumor extension into the IVC and
concurrent distant metastasis. The overall 5-year survival
rate was 17% after aggressive surgical resection and postop-
erative immunotherapy with interleukin-2; interestingly,
patients in whom metastasis was limited to the lung had sig-
nificantly better survival than those with metastasis to other
sites. In our series, concurrent distant metastasis was recog-
nized in seven cases (20.6%), and all of them were lung
Fig 7. Cumulative survival based on extension level of tumor thrombus with Kaplan-Meier method. Dashed lines indicate SE > 10%.
metastases. Their overall 5-year survival rate was 42.9%, and
presence of synchronous distant metastasis did not signifi-
cantly alter survival. This excellent result is suspected to be
contributed to by postoperative immunotherapy with inter-
feron; however, effectiveness of adjuvant immunotherapy
could not be proved in this series.
We agree with the conclusion of Nesbitt et al15 that all
patients with RCC and IVC tumor thrombus should be
considered for operation. Even in the presence of metasta-
tic disease, prolonged survival is expected in patients who
have partial or complete responses to immunotherapy
after surgery. Furthermore, removal of the primary neo-
plasm along with the IVC tumor thrombus has some pal-
liative roles: improvement of clinical symptoms, removal
of an immediately life-threatening focus of disease, and
reduction of tumor mass before immunotherapy.
CONCLUSIONS
Surgical prognosis in patients with RCC extending into
the IVC was determined by the staging of the tumor, espe-
cially lymph node status, and not by the extension level of
tumor thrombus or the presence of concurrent distant
metastasis. The use of CPB is recommended for the resec-
tion of tumor thrombus extending over the diaphragm.
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